Stem Cell Tx Evaluated for Perianal Fistulas in Crohn’s Disease – Monthly Prescribing Reference (registration)
|
Stem Cell Tx Evaluated for Perianal Fistulas in Crohn's Disease
Monthly Prescribing Reference (registration) Takeda and TiGenix announced positive results from the Phase 3 ADMIRE-CD trial of Cx601 for the treatment of complex perianal fistulas in patients with Crohn's disease. Study findings were published in The Lancet. ADMIRE-CD was a 24-week, randomized … |
